Experimental drugs show promise against migraines

By  | 

People who get chronic migraines may be getting some relief, at a hefty price.

Two experimental drugs could be getting FDA approval next year.

They work by blocking a molecule linked to migraines.

Studies found 40% of patients on those drugs had their number of monthly migraines cut in half.

The injections will be expensive, most likely around $10,000 a year.